Elena Santagostino, MD

Trials

Studies that name Elena Santagostino, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:12 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT06579144 · Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A

  Swedish Orphan Biovitrum · completed · Hemophilia A · study director
• N/A
  NCT03901755 · An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B

  Swedish Orphan Biovitrum · completed · Hemophilia B · study director
• N/A
  NCT03655340 · A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

  Swedish Orphan Biovitrum · completed · Haemophilia B · study director
• Ph4
  NCT02479087 · Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients

  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · unknown · Hemophilia A · study director
• N/A
  NCT01505946 · Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors

  Grifols Italia S.p.A · unknown · Severe Hemophilia A With Inhibitor · principal investigator
• Ph2
  NCT01105546 · rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors

  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · unknown · Hemophilia A With Inhibitors · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.